Posts tagged brain
Articles and news from the latest research reports.
Not getting sleepy? Research explains why hypnosis doesn’t work for all
Not everyone is able to be hypnotized, and new research from the Stanford University School of Medicine shows how the brains of such people differ from those who can easily be.
The study, published in the October issue of Archives of General Psychiatry, uses data from functional and structural magnetic resonance imaging to identify how the areas of the brain associated with executive control and attention tend to have less activity in people who cannot be put into a hypnotic trance.
“There’s never been a brain signature of being hypnotized, and we’re on the verge of identifying one,” said David Spiegel, MD, the paper’s senior author and a professor of psychiatry and behavioral sciences. Such an advance would enable scientists to understand better the mechanisms underlying hypnosis and how it can be used more widely and effectively in clinical settings, added Spiegel, who also directs the Stanford Center for Integrative Medicine.
Spiegel estimates that one-quarter of the patients he sees cannot be hypnotized, though a person’s hypnotizability is not linked with any specific personality trait. “There’s got to be something going on in the brain,” he said.
![New research proves the validity of one of the most promising approaches for combating Alzheimer’s disease (AD) with medicines that treat not just some of the symptoms, but actually stop or prevent the disease itself, scientists are reporting. The study, in the journal ACS Medicinal Chemistry Letters, also identifies a potential new oral drug that the scientists say could lead the way.
Wenhui Hu and colleagues point out that existing drugs for AD provide only “minimal” relief of memory loss and other symptoms, creating an urgent need for new medicines that actually combat the underlying destruction of brain cells. Research suggests that inflammation of nerve cells in the brain is a key part of that process. One medicine, Minozac, is in clinical trials. But Hu says Minozac still has more space to improve its efficacy. So the scientists sifted through compounds with a molecular architecture similar to Minozac in an effort to find more active substances.
The report describes success in doing so. They discovered one compound that appeared especially effective in relieving nerve inflammation and in improving learning and memory in lab mice widely used in AD research. “In general, this study not only proves that countering neuroinflammation is indeed a potential therapeutic strategy for Alzheimer’s disease, but also provides a good lead compound with efficacy comparable to donepezil [an existing AD medicine] for further oral anti-AD drug discovery and development,” the report states.](http://33.media.tumblr.com/tumblr_mbd4avIakE1rog5d1o1_500.gif)
New research proves the validity of one of the most promising approaches for combating Alzheimer’s disease (AD) with medicines that treat not just some of the symptoms, but actually stop or prevent the disease itself, scientists are reporting. The study, in the journal ACS Medicinal Chemistry Letters, also identifies a potential new oral drug that the scientists say could lead the way.
Wenhui Hu and colleagues point out that existing drugs for AD provide only “minimal” relief of memory loss and other symptoms, creating an urgent need for new medicines that actually combat the underlying destruction of brain cells. Research suggests that inflammation of nerve cells in the brain is a key part of that process. One medicine, Minozac, is in clinical trials. But Hu says Minozac still has more space to improve its efficacy. So the scientists sifted through compounds with a molecular architecture similar to Minozac in an effort to find more active substances.
The report describes success in doing so. They discovered one compound that appeared especially effective in relieving nerve inflammation and in improving learning and memory in lab mice widely used in AD research. “In general, this study not only proves that countering neuroinflammation is indeed a potential therapeutic strategy for Alzheimer’s disease, but also provides a good lead compound with efficacy comparable to donepezil [an existing AD medicine] for further oral anti-AD drug discovery and development,” the report states.
Home-Based Assessment Tool for Dementia Screening
Georgia Tech researchers have created a tool that allows adults to screen themselves for early signs of dementia. The home-based computer software is patterned after the paper-and-pencil Clock Drawing Test, one of health care’s most commonly used screening exams for cognitive impairment.
“Technology allows us to check our weight, blood-sugar levels and blood pressure, but not our own cognitive abilities,” said project leader Ellen Yi-Luen Do. “Our ClockMe System helps older adults identify early signs of impairment, while allowing clinicians to quickly analyze the test results and gain valuable insight into the patient’s thought processes.”
Georgia Tech’s ClockMe system eliminates the paper trail and computerizes the test into two main components: the ClockReader Application and the ClockAnalyzer Application. Click here to see a video demo.
Mom’s High Blood Pressure in Pregnancy Could Affect Child’s IQ in Old Age
New research suggests that a mother’s high blood pressure during pregnancy may have an effect on her child’s thinking skills all the way into old age. The study is published in the October 3, 2012, online issue of Neurology®, the medical journal of the American Academy of Neurology.
“High blood pressure and related conditions such as preeclampsia complicate about 10 percent of all pregnancies and can affect a baby’s environment in the womb,” said study author Katri Räikönen, PhD, with the University of Helsinki in Finland. “Our study suggests that even declines in thinking abilities in old age could have originated during the prenatal period when the majority of the development of brain structure and function occurs.”
Researchers looked at medical records for the mother’s blood pressure in pregnancy for 398 men who were born between 1934 and 1944. The men’s thinking abilities were tested at age 20 and then again at an average age of 69. Tests measured language skills, math reasoning and visual and spatial relationships.
The study found that men whose mothers had high blood pressure while pregnant scored 4.36 points lower on thinking ability tests at age 69 compared to men whose mothers did not have high blood pressure. The group also scored lower at the age of 20 and had a greater decline in their scores over the decades than those whose mothers did not have problems with blood pressure. The finding was strongest for math-related reasoning.
The researchers also looked at whether premature birth affected these findings and found no change. Whether the baby’s father was a manual laborer or an office worker also did not change the results.
Battling back from a brain injury
Much of the recent attention on traumatic brain injury has focused on the increased risk of neurodegenerative diseases doctors think recurrent injuries may lead to. But transportation accidents and falls, particularly among the elderly, are leading causes of TBI, and one serious head injury can be devastating. Karl Weisgraber is a retired biochemist who worked on cardiovascular and Alzheimer’s research at the Gladstone Institutes in San Francisco. In October of last year, he was on a ladder doing work on the side of his house when he fell and smacked his head on a rock, suffering a severe traumatic brain injury. The 71-year-old Walnut Creek man spent three weeks in a coma and, through therapy, had to relearn how to walk, read and write. He is greatly appreciative of the staffs at San Francisco General and California Pacific Medical Center who worked with him, and of his wife, Judi.
New findings on the workings of the inner ear
The sensory cells of the inner ear have tiny hairs called stereocilia that play a critical part in hearing. It has long been known that these stereocilia move sideways back and forth in a wave-like motion when stimulated by a sound wave. After having designed a microscope to observe these movements, a research team at Karolinska Institutet has discovered that the hairs not only move sideways but also change in length.
The discovery, which was made in collaboration with scientists at Baylor College of Medicine in Texas, USA provides new fundamental knowledge about the mechanisms of hearing. It is presented in the online scientific journal Nature Communications.
(Source: ki.se)
A novel function for p27 protein in the control of interneuron migration in the developing cerebral cortex
These results by GIGA-Neurosciences researchers (University of Liège, Belgium) increase our understanding of the mechanisms that drive neuronal migration in the cerebral cortex. Disruption of neuronal migration is associated with various neurological disorders characterized by mental retardation, epilepsy, learning disabilities, or autism.
In a study published in Developmental Cell, the group of Laurent Nguyen, Research Associate of the FRS-FNRS and WELBIO investigator at GIGA-Neurosciences (University of Liège) has discovered a novel function for p27 in the control of interneuron migration in the developing cerebral cortex.
The Connectome Debate: Is Mapping the Mind of a Worm Worth It?
In the 1970s biologist Sydney Brenner and his colleagues began preserving tiny hermaphroditic roundworms known as Caenorhabditis elegans in agar and osmium fixative, slicing up their bodies like pepperoni and photographing their cells through a powerful electron microscope. The goal was to create a wiring diagram—a map of all 302 neurons in the C. elegans nervous system as well as all the 7,000 connections, or synapses, between those neurons. In 1986 the scientists published a near complete draft of the diagram. More than 20 years later, Dmitri Chklovskii of Janelia Farm Research Campus and his collaborators published an even more comprehensive version. Today, scientists call such diagrams “connectomes.”
So far, C. elegans is the only organism that boasts a complete connectome. Researchers are also working on connectomes for the fruit fly nervous system and the mouse brain. In recent years some neuroscientists have proposed creating a connectome for the entire human brain—or at least big chunks of it. Perhaps the most famous proponent of connectomics is Sebastian Seung of the Massachusetts Institute of Technology, whose impressive credentials, TED talk, popular book, charisma and distinctive fashion sense (he is known to wear gold sneakers) have made him a veritable neuroscience rock star.
New research model to aid search for degenerative disease cures
Efforts to treat disorders like Lou Gehrig’s disease, Paget’s disease, inclusion body myopathy and dementiawill receive a considerable boost from a new research model created by UC Irvine scientists.
The team, led by pediatrician Dr. Virginia Kimonis, has developed a genetically modified mouse that exhibits many of the clinical features of human diseases largely triggered by mutations in the valosin-containing protein.
The mouse model will let researchers study how these now-incurable, degenerative disorders progress in vivo and will provide a platform for translational studies that could lead to lifesaving treatments.
“Currently, there are no effective therapies for VCP-associated diseases and related neurodegenerative disorders,” said Kimonis, a professor of pediatrics who specializes in genetics and metabolism. “This model will significantly spark new approaches to research directed toward the creation of novel treatment strategies.”
She and her team reported their discovery Sept. 28 online in PLOS ONE, a peer-reviewed, open-access journal.
The UCI researchers – from pediatrics, neurology, pathology and radiological sciences – specifically bred the first-ever “knock-in” mouse in which the normal VCP gene was substituted with one containing the common R155H mutation seen in humans with VCP-linked diseases. Subsequently, these mice exhibited the same muscle, brain and spinal cord pathology and bone abnormalities as these patients.
VCP is part of a system that maintains cell health by breaking down and clearing away old and damaged proteins that are no longer necessary. Mutations in the VCP gene disrupt the demolition process, and, as a result, excess and abnormal proteins may build up in muscle, bone and brain cells. These proteins form clumps that interfere with the cells’ normal functions and can lead to a range of disorders.
Another study carried out by members of this group – and published in August in the journal Cell Death & Disease – made use of these genetically altered mice to examine the development of Lou Gehrig’s disease, or ALS. The researchers, led by Dr. Hong Yin and Dr. John Weiss in UCI’s Department of Neurology, documented slow, extensive pathological changes in the spinal cord remarkably similar to changes observed in other animal models of ALS as well as in human patients. ALS research is currently limited by a paucity of animal models in which disease processes can be studied.
Genetically modified mice have become important research models in the effort to cure human ailments. Mice bred to exhibit the brain pathology of Alzheimer’s disease, for example, have dramatically sped up the race to advance new treatments – one such model was developed at UCI. And many cancer therapies were created and tested using genetically altered mice.
(Source: today.uci.edu)
Using a high-tech imaging process to measure the thickness of the eye’s retina may one day predict the progression of multiple sclerosis, a new study suggests.
The finding might lead to better ways to judge the effectiveness of treatments because different parts of the retina seem to indicate different aspects of the disease and the toll it takes on different parts of the brain, the researchers said.
The report was published online Oct. 1 in the Archives of Neurology.